Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03974152 · ClinicalTrials.gov registry record · NA
Effects of Nicotine Salt Aerosol on Cigarette Smokers
A NA study, sponsored by Eastern Virginia Medical School.
- Terminated
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03974152 is a NA study that was terminated before completion, run by Eastern Virginia Medical School. The registered enrollment target is 11 participants.
The verdict
NCT03974152, a NA study, was terminated before completion, sponsored by Eastern Virginia Medical School.
- TERMINATED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This grant compares the effects of cigarette smoking, protonated nicotine ("salt") aerosol through an Electronic Nicotine Delivery System (ENDS), and unprotonated nicotine aerosol through an ENDS on nicotine delivery, nicotine craving, and other outcomes in cigarette smokers.
Interventions
- OTHER Subox Mini C with Avail 18 mg nicotine salt (protonated)
- OTHER Subox Mini C with Avail 18 mg nicotine (unprotonated)
- OTHER Own brand cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-06-10 |
| Est. Completion | 2020-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03974152
The ClinicalTrials.gov registry entry for NCT03974152 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Virginia Medical School, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Subox Mini C with Avail 18 mg nicotine salt (protonated) is the first listed.
NCT03974152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03974152 about?
NCT03974152 is a clinical study titled "Effects of Nicotine Salt Aerosol on Cigarette Smokers". This grant compares the effects of cigarette smoking, protonated nicotine ("salt") aerosol through an Electronic Nicotine Delivery System (ENDS), and unprotonated nicotine aerosol through an ENDS on nicotine delivery, nicotine craving, and other outcomes in cigarette smokers.
What is the current status of trial NCT03974152?
This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2019-06-10. Estimated completion is 2020-03-05.
What interventions are being tested in trial NCT03974152?
The interventions under investigation include: Subox Mini C with Avail 18 mg nicotine salt (protonated) (OTHER), Subox Mini C with Avail 18 mg nicotine (unprotonated) (OTHER), Own brand cigarette (OTHER).
Who is sponsoring clinical trial NCT03974152?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.